https://www.selleckchem.com/pr....oducts/ttnpb-arotino
Axial spondyloarthritis (axSpA) includes ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (nr-axSpA). Both are managed with biologic therapies; however, there is a lack of evidence for nr-axSpA therapies. The primary objective was to compare persistence to first biologic between AS and nr-axSpA patients in a longitudinal cohort. Secondary objectives were to examine disease activity markers over time and to evaluate predictors for drug discontinuation. Data were obtained from persons enrolled in the Sp
Like
Comment
Share
